Iron deficiency anemia: Impact on women's reproductive health

Fertil Steril. 2022 Oct;118(4):605-606. doi: 10.1016/j.fertnstert.2022.08.850.

Abstract

Iron deficiency (ID) and iron deficiency anemia (IDA) are highly prevalent among women across their life span, especially during the reproductive age. An iron-deficient state has been associated with a number of adverse health consequences, affecting all aspects of the physical and emotional well-being of women. Heavy menstrual bleeding, pregnancy state, and the postpartum period are the major causes of ID/IDA. However, despite the high prevalence and the impact on quality of life, ID/IDA among fertile age women remains underdiagnosed and undertreated. The present Views and Reviews provides an overview on IDA in women's health, describing the background on iron metabolism, heavy menstrual bleeding pathogenetic mechanisms, including a focus on uterine disorders, such as uterine fibroids and adenomyosis. Iron replacement therapies, patient blood management, and treatment options for uterine disorders also are explored.

Keywords: Anemia; heavy menstrual bleeding; iron deficiency; reproduction.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia, Iron-Deficiency* / diagnosis
  • Anemia, Iron-Deficiency* / epidemiology
  • Anemia, Iron-Deficiency* / etiology
  • Female
  • Humans
  • Iron
  • Iron Deficiencies*
  • Menorrhagia* / diagnosis
  • Menorrhagia* / epidemiology
  • Menorrhagia* / etiology
  • Pregnancy
  • Quality of Life
  • Reproductive Health
  • Women's Health

Substances

  • Iron